Is sorafenib plus interferon α2b safe and effective in patents with renal cell carcinoma?

被引:4
作者
Rini, Brian I. [1 ]
机构
[1] Cleveland Clin, Dept Solid Tumor Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
来源
NATURE CLINICAL PRACTICE UROLOGY | 2008年 / 5卷 / 03期
关键词
combination; efficacy; interferon alpha; renal cell carcinoma; sorafenib;
D O I
10.1038/ncpuro1036
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:132 / 133
页数:2
相关论文
共 6 条
  • [1] Amato RJ, 2007, J CLIN ONCOL, V25
  • [2] Sorafenib in advanced clear-cell renal-cell carcinoma
    Escudier, Bernard
    Eisen, Tim
    Stadler, Walter M.
    Szczylik, Cezary
    Oudard, Stephane
    Siebels, Michael
    Negrier, Sylvie
    Chevreau, Christine
    Solska, Ewa
    Desai, Apurva A.
    Rolland, Frederic
    Demkow, Tomasz
    Hutson, Thomas E.
    Gore, Martin
    Freeman, Scott
    Schwartz, Brian
    Shan, Minghua
    Simantov, Ronit
    Bukowski, Ronald M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) : 125 - 134
  • [3] Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer
    Gollob, Jared A.
    Rathmell, W. Kimryn
    Richmond, Tina M.
    Marino, Christine B.
    Miller, Elizabeth K.
    Grigson, Gayle
    Watkins, Catharine
    Gu, Lin
    Peterson, Bercedis L.
    Wright, John J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3288 - 3295
  • [4] Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
    Hudes, Gary
    Carducci, Michael
    Tomczak, Piotr
    Dutcher, Janice
    Figlin, Robert
    Kapoor, Anil
    Staroslawska, Elzbieta
    Sosman, Jeffrey
    McDermott, David
    Bodrogi, Istvan
    Kovacevic, Zoran
    Lesovoy, Vladimir
    Schmidt-Wolf, Ingo G. H.
    Barbarash, Olga
    Gokmen, Erhan
    O'Toole, Timothy
    Lustgarten, Stephanie
    Moore, Laurence
    Motzer, Robert J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (22) : 2271 - 2281
  • [5] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Tomczak, Piotr
    Michaelson, M. Dror
    Bukowski, Ronald M.
    Rixe, Olivier
    Oudard, Stephane
    Negrier, Sylvie
    Szczylik, Cezary
    Kim, Sindy T.
    Chen, Isan
    Bycott, Paul W.
    Baum, Charles M.
    Figlin, Robert A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) : 115 - 124
  • [6] Ryan CW, 2007, J CLIN ONCOL, V25, P3296, DOI 10.1200/JCO.2007.11.1047